Houston Astros slugger Yordan Alvarez has experienced a setback in his recovery from a broken right hand and will see a specialist. Astros general manager Dana Brown said Alvarez felt pain when he ...

The main asset in Biogen's $1.8bn takeover of HI-Bio, anti-CD38 drug felzartamab, delivers a positive phase 2 readout in rare disease IgAN.

Astros general manager Dana Brown said prior to Houston's 6-5 win over the Rockies on Tuesday night at Coors Field that Alvarez, who’s been out since May 2, was set to see a hand specialist after ...